Skip to main content

eTheRNA collaborates with Quantoom Biosciences on RNA Production System

  • June 29, 2021

eTheRNA immunotherapies, a clinical-stage company and VUB spin-off developing mRNA-based immunotherapies with in-house GMP certified production and process development capabilities, and Quantoom Biosciences announced that they will collaborate on the development of a revolutionary RNA production system (RPS) for both research and GMP-grade material.          

Quantoom and eTheRNA will work together to build an advanced, small footprint technology platform for the production of affordable RNA-based therapies, that can be used either within existing facilities or rapidly deployed to areas of urgent need. 

Quantoom Biosciences is a Belgian biotech company aiming to improve access to essential medicines through innovative bioproduction methods. 

Read more